Return to search

Evaluating PrediXcan’s Ability to Predict Differential Expression Between Alcoholics and Non-Alcoholics

PrediXcan is a recent software for the imputation of gene expression from genotype data alone. Using an overlapping set of transcriptome datasets from postmortem brain tissues of donors with alcohol use disorder and neurotypical controls, which were generated by two different platforms (e.g., Arraystar and Affymetrix), and an additional unrelated transcriptome dataset from lung tissue, we sought to evaluate PrediXcan’s ability to impute gene expression and identify differentially expressed genes. From the Arraystar platform, 1.3% of matched genes between the measured and imputed expression had a Pearson correlation ≥ 0.5. Our attempt to replicate this finding using the expression data from the Affymetrix platform also lead to a similarly poor outcome (2.7%). Our third attempt using the transcriptome data from lung tissue produced similar results (1.1%) but performance improved markedly after filtering out genes with a low predicted R2, which was a model metric provided by the PrediXcan authors. For example, filtering out genes with a predicted R2 below 0.6 led to 16 genes remaining and a Pearson correlation of 0.365 between the measured and imputed expression. We were unable to reproduce similar performance gains with filtering the Arraystar or Affymetrix alcohol use disorder datasets. Given that PrediXcan can impute a narrow portion of the transcriptome, which is further reduced significantly by filtering, we believe caution is warranted with the interpretation of results derived from PrediXcan.

Identiferoai:union.ndltd.org:vcu.edu/oai:scholarscompass.vcu.edu:etd-6930
Date01 January 2019
CreatorsDrake, John E, Jr
PublisherVCU Scholars Compass
Source SetsVirginia Commonwealth University
Detected LanguageEnglish
Typetext
Formatapplication/pdf
SourceTheses and Dissertations
Rights© The Author

Page generated in 0.0015 seconds